Cart 0
Diabetes Care Market

Diabetes Care Market - Forecasts from 2017 to 2022

  • $3,800.00
  • Publishing Date: January 2017
  • Format: PDF
Sample Request

Diabetes is a condition which impacts the overall body of humans. It is also known as diabetes mellitus by doctors and is characterized by a symptom in which the blood sugar level of the body becomes very high. Patients with high blood sugar level develop polyuria which causes them to frequently urinate or polydipsia and polyphagia which makes them excessively hungry and thirsty respectively. The body’s ability to produce or use insulin is heavily impacted. Insulin is a hormone present in the body which is released to transport the energy that is produced by processing the food humans eat. Insulin transports the energy produced by the cells and signals the cell to open and receive sugar. If little or no insulin is present in the body, then a high amount of sugar gets remained in the blood which can be dangerous. Primarily two types of diabetes are there type 1 and type 2. Under type 1, the pancreas does not produce insulin and it usually occurs in humans during childhood or adolescence, though it can occur in adults, the possibility is less. Under type 2 diabetes, the body is not able to produce sufficient insulin or use it properly.  It occurs generally after the age of 45. Various factors can contribute to the growth of type 2 diabetes such as genetic conditions, extra weight, high cholesterol, high blood pressure and bad communication between cells. Moreover, there is gestational diabetes which affects women during pregnancy.

Market Dynamics

Diabetes care devices are manufactured with an aim to help the patient in the management or monitoring of blood sugar levels due to inadequate insulin production or insulin resistance.  Devices such as glucose monitoring device and insulin delivery device are instruments used for diabetes care. The diabetes care market is predominantly driven by rising number of diabetic cases across the globe, improved research and development activities on diabetes in combination with increasing collaborations and investment by various market players. Moreover, factors like innovative technologies used for diabetic care devices, improper diet or erratic lifestyle and increasing need for faster and safer diagnosis and treatment of diabetes drive this market globally. Increased knowledge about this disease, wide scope of penetration in untapped and emerging markets also contribute towards the market growth.  However, factors like high price charged with diagnosis and treatment of diabetes, low awareness regarding reimbursement issues and patent expiry and a stringent framework which controls the diabetic procedures act as impediments to the market growth.

Geographic outlook

North America makes one of the largest markets for global diabetes care due to the increasing awareness across its population about diabetes symptoms and an adverse effect of high glucose level in blood. Furthermore, strong healthcare infrastructure, better research, and technological advancements, as well as rising interest of the public for better healthcare facilities, create an opportunity for diabetes care device market in this region. The government spending for health sector also provides an impetus for the growth of this market in this region. The market for diabetes care in Europe is witnessing an upward trend on account of the presence of a good chunk of the adult population with diabetes. Hence, the presence of a diabetic population in Europe signifies the market boost for diabetes care market in the region. Furthermore, technological advancements and healthcare research and development activities also impact the market growth significantly. APAC region also provides tremendous opportunities for its two gigantic countries India and China are home to many diabetic patients.


Diabetes care market has been segmented on the basis of diabetes care devices, therapy type, and geography as follows:

  • By Diabetes Care Devices
    • Insulin Delivery Devices
      • Pens
      • Pumps
      • Syringes
    • Glucose Monitoring Devices
      • Continuous Glucose Monitoring Devices
      • Lancing Device
      • HbA1c testing kits
      • Blood Glucose Test Strips and Meters
    • By Therapy Type
      • Injectable
      • Oral Drugs
    • By Geography
      • Americas
        • North America
        • South America
      • Europe Middle East and Africa
        • Europe
        • The Middle East and Africa
      • Asia Pacific

Market Players

Competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Roche Diagnostics, Johnson & Johnson, Ascensia Diabetes Care Holdings, Medtronic MiniMed, Abbott, Becton, and Dickinson and Company.

1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics

4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Porter's Five Forces
4.6. Supplier Outlook
4.7. Industry Outlook
4.8. Industry Value Chain Analysis
4.9. Scenario Analysis
5. Global Diabetes Care Market Forecast by Diabetes Care Devices 
5.1. Insulin Delivery Devices
5.1.1. Pens
5.1.2. Pumps
5.1.3. Syringes
5.2. Glucose Monitoring Devices
5.2.1. Continuous Glucose Monitoring Devices
5.2.2. Lancing Device
5.2.3. HbA1c testing kits
5.2.4. Blood Glucose Test Strips and Meters
6. Global Diabetes Care Market Forecast by Therapy Type
6.1. Injectable
6.2. Oral Drugs
7. Global Diabetes Care Market Forecast by Geography 
7.1. Americas
7.1.1. North America
7.1.2. South America
7.2. Europe Middle East and Africa
7.2.1. Europe
7.2.2. Middle East and Africa
7.3. Asia Pacific
8. Competitive Intelligence
8.1. Market Share of Key Players
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players
9. Company Profiles
9.1. Roche Diagnostics
9.2. Johnson & Johnson
9.3. Sanofi
9.4. Novo Nordisk
9.5. Ypsomed
9.6. Ascensia Diabetes Care
9.7. Medtronic MiniMed
9.8. Dexcom
9.10. Terumo Europe
9.11. Abbott
9.12. Becton, Dickinson and Company
9.13. ACON Laboratories

Related Reports
Back to the top